{"id":904390,"date":"2025-11-03T11:42:27","date_gmt":"2025-11-03T16:42:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/"},"modified":"2025-11-03T11:42:27","modified_gmt":"2025-11-03T16:42:27","slug":"nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/","title":{"rendered":"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n PHILADELPHIA<\/span>
\n <\/span>, Nov. 3, 2025<\/span><\/span> \/PRNewswire\/ —\u00a0National plaintiffs’ law firm Berger Montague PC<\/span><\/a><\/u>\u00a0announces a class action lawsuit against Marex Group plc (NASDAQ: MRX)<\/b> (“Marex” or the “Company”) on behalf of investors who purchased Marex shares during the period of\u00a0May 16, 2024<\/span> through August 5, 2025<\/span><\/b>(the “Class Period”).<\/p>\n

\n

\n
\n \"A
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n
\n Investor Deadline:<\/i>
\n <\/b>
\n Investors who purchased or acquired Marex\u00a0securities during the Class Period may, no later than December 8, 2025<\/span><\/b>, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,<\/i>
\n
\n
\n CLICK HERE<\/a>
\n <\/u>
\n <\/b>.<\/p>\n

Marex, headquartered in London<\/span>, provides global financial services including trading, clearing, and risk management.<\/p>\n

According to the Complaint, on August 5, 2025<\/span>, NINGI Research released an extensive report detailing financial improprieties by Marex, including that the Company had engaged in a multi-year accounting scheme involving opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures designed to conceal losses, inflate profits, and mask risk exposure. The report identified numerous multi-million-dollar discrepancies in intercompany receivables and loans across over 56 entities.<\/p>\n

It is further alleged<\/span> that Marex concealed nearly $1 billion<\/span> in off-balance-sheet derivatives through a Luxembourg<\/span> fund controlled by the Company, generating non-cash profits and inflating operating cash flow by misclassifying structured note issuance as income.<\/p>\n

Following the report, Marex’s stock price dropped $2.33<\/span>, or 6.2%, closing at $35.31<\/span> amid heavy trading volume, causing investor losses.\u00a0<\/p>\n

\n
\n If you are a Marex investor and would like to learn more about this action, <\/i>
\n <\/b>
\n
\n
\n
\n CLICK HERE<\/a>
\n <\/u>
\n <\/i>
\n <\/b>\u00a0or please contact Berger Montague<\/span>: Andrew Abramowitz<\/span> at <\/i><\/b>aabramowitz@bergermontague.com<\/a><\/u><\/i><\/b> or (215) 875-3015, or Caitlin Adorni<\/span> at <\/i><\/b>cadorni@bergermontague.com<\/a><\/u><\/i><\/b> or (267)764-4865.<\/i><\/b><\/p>\n

\n About Berger Montague<\/span>
<\/b>
\n Berger Montague<\/span>, with offices in Philadelphia<\/span>, Minneapolis<\/span>, Delaware<\/span>, Washington, D.C.<\/span>, San Diego<\/span>, San Francisco<\/span>, Chicago<\/span>, Malvern, PA<\/span>, and Toronto<\/span> has been a pioneer in securities class action litigation<\/a><\/u>\u00a0since its founding in 1970. Berger Montague<\/span> has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States<\/span>.<\/p>\n

\n For more information or to discuss your rights, please contact:
<\/b>
\n Andrew Abramowitz<\/span>
\n
\n Senior Counsel
<\/i>
\n Berger Montague<\/span>
\n
(215) 875-3015
aabramowitz@bergermontague.com<\/a><\/p>\n

\n Caitlin Adorni<\/span>
\n
\n Director of Portfolio & Institutional Client Monitoring Services
<\/i>
\n Berger Montague<\/span>
\n
(267) 764-4865
cadorni@bergermontague.com<\/a>\u00a0<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline-302602195.html<\/a><\/p>\n

SOURCE Berger Montague<\/span><\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire PHILADELPHIA , Nov. 3, 2025 \/PRNewswire\/ —\u00a0National plaintiffs’ law firm Berger Montague PC\u00a0announces a class action lawsuit against Marex Group plc (NASDAQ: MRX) (“Marex” or the “Company”) on behalf of investors who purchased Marex shares during the period of\u00a0May 16, 2024 through August 5, 2025(the “Class Period”). Investor Deadline: Investors who purchased or acquired Marex\u00a0securities during the Class Period may, no later than December 8, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE . Marex, headquartered in London, provides global financial services including trading, clearing, and risk management. According to the Complaint, on August 5, 2025, NINGI Research released an extensive report detailing financial improprieties by Marex, … <\/p>\n

Continue reading “NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904390","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PHILADELPHIA , Nov. 3, 2025 \/PRNewswire\/ —\u00a0National plaintiffs’ law firm Berger Montague PC\u00a0announces a class action lawsuit against Marex Group plc (NASDAQ: MRX) (“Marex” or the “Company”) on behalf of investors who purchased Marex shares during the period of\u00a0May 16, 2024 through August 5, 2025(the “Class Period”). Investor Deadline: Investors who purchased or acquired Marex\u00a0securities during the Class Period may, no later than December 8, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE . Marex, headquartered in London, provides global financial services including trading, clearing, and risk management. According to the Complaint, on August 5, 2025, NINGI Research released an extensive report detailing financial improprieties by Marex, … Continue reading "NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T16:42:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline\",\"datePublished\":\"2025-11-03T16:42:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/\"},\"wordCount\":379,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/\",\"name\":\"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"datePublished\":\"2025-11-03T16:42:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/","og_locale":"en_US","og_type":"article","og_title":"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline - Market Newsdesk","og_description":"PR Newswire PHILADELPHIA , Nov. 3, 2025 \/PRNewswire\/ —\u00a0National plaintiffs’ law firm Berger Montague PC\u00a0announces a class action lawsuit against Marex Group plc (NASDAQ: MRX) (“Marex” or the “Company”) on behalf of investors who purchased Marex shares during the period of\u00a0May 16, 2024 through August 5, 2025(the “Class Period”). Investor Deadline: Investors who purchased or acquired Marex\u00a0securities during the Class Period may, no later than December 8, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE . Marex, headquartered in London, provides global financial services including trading, clearing, and risk management. According to the Complaint, on August 5, 2025, NINGI Research released an extensive report detailing financial improprieties by Marex, … Continue reading \"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T16:42:27+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline","datePublished":"2025-11-03T16:42:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/"},"wordCount":379,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/","name":"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","datePublished":"2025-11-03T16:42:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrx-investor-alert-berger-montague-advises-marex-group-plc-nasdaq-mrx-investors-of-a-december-8-2025-deadline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904390"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904390\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}